N,N,N',N'-Ethylenediaminetetrakis
CAS : 1429-50-1
Ref. 3D-FE75418
2g | 136,00 € | ||
5g | 192,00 € | ||
10g | 217,00 € | ||
25g | 324,00 € | ||
50g | 406,00 € |
Informations sur le produit
- ([[2-(Bis-phosphonomethyl-amino)-ethyl]-phosphonomethyl-amino]-methyl)-phosphonic acid
- 1,2-Ethanediylbis[nitrilobis(methylene)]tetrakisphosphonic acid
- Acide [ethane-1,2-diylbis[nitrilobis(methylene)]]tetrakisphosphonique
- Acido [Etano-1,2-Diilbis[Nitrilobis(Metilen)]]Tetrakisfosfonico
- Aethylendinitrilo-Tetrakis-(Methylenphosphonsaeure)
- Briquest 422-25S
- Chelating agent 540
- Chelest PH 540
- Cublen 3115
- Cublen E 950
- Voir d'autres synonymes
- Dequest 2040
- Dequest 2041
- EDPA (chelating agent)
- Editempa
- Edpa
- Edtf
- Edtmp
- Edtmpa
- Edtmps
- Edtpa
- Edtph
- Ethylenedi(nitrilodimethylene)tetraphosphonic acid
- Ethylenediamine tetra (methylenephosphonic acid)
- Ethylenediamine-N,N,N',N'-tetra(methylphosphonic acid)
- Ethylenediamine-N,N,N',N'-tetrakis(methylenephosphonic acid)
- Ethylenediaminetetra(methylenephosphonic acid)
- Ethylenediaminetetrakis(methylenephosphonic acid)
- Ethylenediaminetetrakis(methylphosphonic acid)
- Ethylenediaminetetramethylenephosphonate
- Ethylenediaminotetra(methylenephosphonic acid)
- N,N,N',N'-Tetrakis (phosphonomethyl) ethylenediamine
- P,P′,P′′,P′′′-[1,2-Ethanediylbis[nitrilobis(methylene)]]tetrakis[phosphonic acid]
- Ph 540
- Phosphonic acid, P,P',P'',P'''-[1,2-ethanediylbis[nitrilobis(methylene)]]tetrakis-
- Phosphonic acid, [ethylenebis(nitrilodimethylene)]tetra-
- Wayplex 45K
- [2-[Bis(phosphonomethyl)amino]ethyl-(phosphonomethyl)amino]methylphosphonic acid
- [Ethan-1,2-diylbis[nitrilobis(methylen)]]tetrakisphosphonsaure
- [Ethane-1,2-Diylbis[Nitrilobis(Methylene)]]Tetrakisphosphonic Acid
- [Ethylenebis(nitrilodimethylene)]tetraphosphonic acid
N,N,N',N'-Ethylenediaminetetrakis (EDTA) is a chelating agent that has been shown to be effective in the treatment of parathyroid tumours. It is administered intravenously and has been shown to bind to phosphonic acid in the body and prevent its accumulation in the bones. This prevents the development of osteoblastic lesions, which may lead to bone pain and fractures. EDTA has also been shown to have relatively low toxicity with no detectable side effects on animals. The biodistribution and uptake of this drug was monitored using scintigraphy following intravenous injection in rats. EDTA was found to be taken up by all tissues equally and distributed evenly throughout the body.
Propriétés chimiques
Question d’ordre technique sur : 3D-FE75418 N,N,N',N'-Ethylenediaminetetrakis
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages